Researchers in the US are hoping that their new breast cancer vaccine will be effective in humans because it safely destroyed HER2-positive tumors, even those resistant to anti-HER2 drugs, when tested on mice. The study was the work of scientists at the School of Medicine and Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, and is published in the September 15 issue of Cancer Research, a journal of the American Association for Cancer Research.
More...
Linear Mode
